Dr. Reddy's Laboratories
RDY
#1831
Rank
C$15.56 B
Marketcap
C$18.65
Share price
0.59%
Change (1 day)
-2.62%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): C$1.21 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are C$3.95 Billion. a decrease over its 2024 earnings that were of C$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 C$1.18 B-2.73%
2024 C$1.22 B7.01%
2023 C$1.14 B17.62%
2022 C$0.96 B43.27%
2021 C$0.67 B31.44%
2020 C$0.51 B54.54%
2019 C$0.33 B-12.26%
2018 C$0.37 B23.6%
2017 C$0.30 B4.47%
2016 C$0.29 B-55.7%
2015 C$0.66 B1.83%
2014 C$0.65 B-3.78%
2013 C$0.67 B54.07%
2012 C$0.43 B-16.23%
2011 C$0.52 B56.66%
2010 C$0.33 B-235.36%
2009 -C$0.25 Billion-198.53%
2008 C$0.25 B30.77%
2007 C$0.19 B-14.61%
2006 C$0.22 B703.63%
2005 C$27.99 M649.45%
2004 C$3.73 M-95.68%
2003 C$86.37 M-14.86%
2002 C$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.22 B 1,772.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$13.85 B 1,066.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.46 B 781.57%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
C$13.44 B 1,033.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$2.92 B 146.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel